Both African-American women and Hispanic women are diagnosed with breast cancer at later stages than white women. 1, 2 Later stage of breast cancer at diagnosis is associated with lower use of mammography [3] [4] [5] and delays in diagnosis after discovery of a breast abnormality. 6 Besides advanced disease stage and poorer survival, 7 delay in timely follow-up after an abnormal result is associated with considerable anxiety and emotional distress. 8 -11 In addition, delay in diagnosis of breast cancer is the most common cause of malpractice lawsuits against physicians in the United States. 12 Although there is much literature on factors associated with use of mammography, less is known about the interval between an abnormal screening examination and definitive diagnosis (diagnostic interval). In studies conducted in the United States over the past decade, factors found to be associated with shorter diagnostic intervals include white race, [13] [14] [15] [16] age Ͻ50, 17 having private or managed care insurance, 18, 19 ease of access to health care 20 and surgical evaluation, 21 more severe mammogram abnormality, 14, 22 better communication at time of mammogram, 22 inclusion of specific follow-up recommendations in the mammogram report, 17, 18 higher patient anxiety, 20 and patients with a malignant outcome. 21 Although specialty of a patient's usual provider of care is associated with stage of breast cancer diagnosis and use of mammography, it is unknown if specialty of a patient's usual provider of care affects time from discovery of breast abnormality to diagnosis. Increased supply and use of primary care physicians result in earlier diagnosis for breast cancer, 23, 24 and the likelihood of a patient receiving a mammogram is greater if she is assigned a primary care provider (as occurs in some HMO plans for example) or her usual physician is a primary care provider. [25] [26] [27] One study of 184 Black women in New York found that specialty of primary care provider was not associated with timely diagnostic resolution of an abnormal breast screening examination, however the sample size in that study may not have been enough to detect differences. 22 In studies that did not find racial differences in the diagnostic interval after abnormal breast screening exams, all women had a primary care provider, 18, 28 suggesting that having a primary care provider may eliminate the racial disparity in timely diagnosis after an abnormal breast screening examination.
The purpose of this study is to determine whether having a primary care provider and specialty of the primary care provider is associated with timeliness in diagnosis after discovery of breast abnormality in minority women. We hypothesize that women who have a family physician as the usual provider of care will have shorter diagnostic intervals.
Methods

Sample
This was a retrospective cross-sectional chart review study of all 723 patients who received breast biopsies at an urban university hospital from February 2001 to March 2005. This public hospital serves a predominantly low-income minority population with over 50% Black and 30% Hispanic patients. Forty percent of patients are uninsured, and 30% have Medicaid insurance. Patients were identified through a list of pathology reports of breast biopsies and confirmed with a list of breast biopsies performed from the primary breast surgeon of the hospital. Patients were excluded if they were male, did not have an outpatient chart, or if they were referred from outside the institution and did not have a documented date of abnormal mammogram report or initial clinical breast examination.
This study was reviewed and approved by the University of Medicine and Dentistry of New Jersey-New Jersey Medical School Institutional Review Board, which waived the requirement for informed consent of individual patients for this retrospective chart review study.
Instruments and Measures
The main outcome variables of interest were diagnostic interval and diagnostic delay. The diagnostic interval was defined as the time (in days) from abnormal mammogram to final pathology report. In women who did not have a mammogram report available but had an initial abnormal clinical examination (N ϭ 34), the diagnostic interval was defined as the time (in days) from abnormal clinical examination to final pathology report. Diagnostic delay was defined as a diagnostic interval longer than 60 days. A 60-day delay may have little biologic consequence in terms of outcomes for breast cancer, but it may cause considerable anxiety and emotional distress. Furthermore, a diagnostic interval of 60 days has been used by other studies to determine delay, 11, 14, 17 and the CDC has set 60 days as the program standard for receiving a final diagnosis after an abnormal breast screening result. 29 The main independent variable of interest was specialty of usual provider of care, defined as the type of doctor (primary care versus not primary care) to whom the patient had the most visits to in the year before the mammogram. If this was a primary care physician, then the specialty of primary care physician was also determined (family medicine, internal medicine, obstetrician-gynecologist). "Other" refers to patients whose usual provider of care was a specialist. "None" refers to patients who did not have a primary care physician or specialist as their usual provider of care (they were referred from our emergency department or through our free mammography screening program.) "Other" and "none" were combined in statistical analysis because we wanted to compare persons whose usual source of care is a primary care provider versus no primary care provider. For patients who were referred from outside the facility, the specialty of the primary care physician who referred the patient for breast evaluation was considered the usual provider of care.
Other predictor variables included age at biopsy, race/ethnicity (non-Hispanic white, non-Hispanic Black, Hispanic, other), insurance (uninsured, Medicaid, Medicare, private), smoking status (never, current, former), marital status (married, single, separated/divorced/widowed), employment (unemployed, employed/retired), personal history of breast cancer (yes, no), family history of breast cancer (yes, no), whether a clinician felt a lump (yes, no), whether the patient felt a lump (yes, no), and final pathology result (benign, cancer).
Procedures
Three chart abstractors were trained by the principal investigator to conduct chart reviews in a systematic fashion using the hospital's electronic medical record system. Data were abstracted from progress notes, registration, lab tests, and x-rays. Information abstracted from the charts included date of mammogram, date of initial clinical examination, date of breast clinic visit, and date of biopsy report. In addition, basic demographic data and other factors that might affect diagnostic interval were recorded (see variables above).
At the beginning of data collection, interrater reliability for chart abstractors was assessed for the major outcome and predictor variables by re-reviewing a sample of 28 charts from each abstractor and calculating the kappa statistic. Kappa statistics for main outcome and predictor variables ranged from ϭ 0.83 to 1.0. Ongoing monitoring of data quality was accomplished via intrarater reliability; chart abstractors re-reviewed 10% of charts. Kappa statistics ranged from ϭ 0.82 to 1.0. Any discrepancies were reviewed by the principal investigator and data were corrected.
Statistical Analysis
Descriptive statistics were used to describe the baseline characteristics of the study population and the diagnostic interval. Because the distribution of diagnostic intervals was skewed, we compared median diagnostic intervals among independent variables rather than means to give a more accurate picture of the true distributions, using the KruskalWallis test to assess statistical significance. We also compared the percentages of women with diagnostic delay, using the 2 test for categorical variables and the Fisher's exact test for dichotomous variables. Multivariate analysis was done to determine significant independent predictors of time to diagnosis. Logistic regression was conducted to assess predictors of diagnostic delay. Variables included in the logistic regression model were those determined a priori (age, race, primary care provider) as well as those found to be significant in bivariate analysis (for diagnostic delay) at P Ͻ .10. To avoid collinearity problems, palpable lump by patient and palpable lump by clinician were not placed in the models at the same time. Analyses used two-sided P values with ␣ set at .05. All the analyses were performed using version 12 of SPSS (Chicago, IL).
Results
Data were collected from 723 patient charts; 24.5% of charts were excluded for the following reasons: the patient was male (2.0%), the patient did not have an outpatient chart (8.3%), or if they were referred from outside the institution and did not have a documented date of abnormal mammogram or initial clinical breast examination (14.1%). This left an analytic sample of 546 patients. Table 1 describes the characteristics of the women who had breast biopsies at the hospital. The mean age was 46 years (SD 14.9). The sample population included large percentages of Black (47.5%) and Hispanic (34.7%) patients, uninsured patients (42.1%), and patients lacking a primary care physician (38.8%). A total of 51% of the women felt a lump themselves, and 21% of the women were diagnosed with breast cancer. The median diagnostic interval was 36 days (range 0 to 360; interquartile range [25th percentile to 75th percentile] 21 to 63 days). Table 2 shows the results of bivariate analysis comparing median diagnostic intervals and the proportion of women with a diagnostic interval over 60 days for all the independent variables. Significant predictors of a shorter median diagnostic interval included having private insurance (P ϭ .024), having a family physician (P ϭ .009), cancer diagnosis (P Ͻ .001), and having a lump felt by the patient (P Ͻ .001) or the physician (P ϭ .001). Results were similar when comparing the proportion of women with a diagnostic interval greater than 60 days, except the variable, clinician felt lump, was no longer significant. There were no differences in diagnostic interval or diagnostic delay based on age or race/ethnicity.
Results from the multivariate analysis using logistic regression are shown in Table 3 . After controlling for age, race, insurance, primary care physician, employment status, patient felt lump, and pathology report, factors associated with decreased odds of diagnostic delay were having a family physician, private insurance, and if the pathology was cancerous. In effect, the odds of a diagnosis within 60 days was 4.1 times greater if the primary care provider was a family physician, 2.8 times greater if the patient had private insurance, and 3.1 times greater if the diagnosis was cancer. Results were similar when clinician felt lump was in the model instead of patient felt lump. We also analyzed the data without the group with missing mammograms and the results were similar. There was no significant difference between the 2 groups in the median diagnostic interval (36 days vs. 36.5 days, P ϭ .54) or percentage with diagnostic delay (27% vs. 32%, P ϭ .42). Because the results did not differ, we included the group with missing mammograms to have greater sample size and statistical power.
Discussion
This study is the first to show differences in timely diagnosis of a breast abnormality by specialty of primary care provider. In the one other study that examined the association of specialty of usual provider to diagnostic resolution, provider type was not a significant factor. That study was conducted in underserved Black women from 3 cancer screening clinics in New York City, used 90 days as timely completion of follow-up, combined family medicine and internal medicine, and had some form of patient navigation system in place. In addition, the sample size of 184 patients may not have been enough to detect differences among the different provider types. 22 The results of our study suggest that women receiving care at urban public hospitals can get timely diagnosis of a breast abnormality if they have a family physician as their usual provider of care. This may have a great public health impact given the fact that women receiving care at urban public hospitals are mostly minority race and ethnicity, and minority women have poorer outcomes from breast cancer than white women. 1, 2, 30 Although higher use of mammography has been associated with seeing an obstetrician-gynecologist, compared with other primary care providers, 27,31-33 screening will not be effective without adequate and timely follow-up studies for definitive diagnosis. In addition, only 15% of obstetrician-gynecologists consider themselves primary care providers, compared with 90% of family physicians, 31 so having a family physician for all urban minority women may be a more practical intervention to improve breast outcomes in this population.
We did not have a measure of the relationship with the family physician, so it is unclear what services in particular the family physician provides that promote timelier follow-up of patients. It may be that the physician-patient relationship that has been established through comprehensive and lon- gitudinal care of the patient allows family physicians to better coordinate and insure proper and timely use of specialty and ancillary services. An ongoing relationship with a family physician also leads to increased communication and trust. Trust in a regular primary care physician has been shown to be associated with increase use of mammography 34 and earlier stage at diagnosis of breast cancer. 35 Trust in one's family physician may also increase compliance with follow-up tests and procedures. Further studies are needed to clarify the family physician-patient relationship and how it benefits patients with breast abnormalities.
Women with private insurance had shorter time to resolution after an abnormal mammogram or clinical breast examination. This finding is similar to other studies that found women with managed care insurance or private insurance in addition to Medicare had shorter diagnostic intervals. 18, 19 Women with private insurance may have fewer barriers and more resources than women without insurance and may be more assertive in getting timely diagnosis after an abnormal test result.
It is not surprising that women with a cancer diagnosis on final pathology report had shorter time to diagnosis, as was found in another study.
14 When a mammogram report or a clinical examination is strongly suggestive of malignancy, efforts are usually made to hasten the time to definitive diagnosis and treatment.
Our study has several limitations. First, the sample population consisted of mostly Black and Hispanic women who received medical care in an urban public hospital, so the study results may not be generalized to other populations or other health care settings. However, these findings may be broadly applied to Black and Hispanic women receiving care in urban public hospitals throughout the United States. Second, this was a chart review study, which is limited by lack of documentation of certain variables. For instance, we did not have information on income. However, insurance and employment status can be used as proxies for socioeconomic status. In addition, we did not measure other confounders such as language barriers or use of an interpreter. However, most of our nonEnglish-speaking patients are Hispanic, and we did not find any difference in diagnostic interval based on ethnicity. Finally, because of the retrospective design of this study, we have no knowledge of patients who had an abnormal mammogram that required biopsy but went elsewhere for their care, or had no follow-up at all. We chose women with breast biopsies as our sampling frame, as we were more able to determine diagnostic interval in women who had a definitive diagnosis. For example, some women with abnormal mammograms may just have 6-month follow-ups and that would skew the diagnostic interval in those women. Other women may go elsewhere for their biopsy, and we don't have access to their biopsy reports. Further studies using a prospective design are needed to confirm these results.
In conclusion, in this population of mostly minority women receiving a breast biopsy at an urban public hospital, those who have a family physician, private insurance, or cancer diagnosis have shorter times to diagnosis after discovery of a breast abnor- mality. This study adds to the growing literature about the importance of family physicians in improving health outcomes. 36 To improve timely follow-up of women with breast abnormalities at urban public hospitals, promoting development of a relationship with a family physician may be an important public health intervention.
